Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,578 | -2,823 | -1,401 | -3,485 | -1,921 |
| Depreciation Amortization | 1,176 | 736 | 359 | 1,443 | 1,084 |
| Accounts receivable | -1,662 | -684 | -1,112 | 1,856 | 1,356 |
| Other Working Capital | -3,268 | 857 | -1,373 | 58 | -311 |
| Other Operating Activity | 763 | -1,876 | 1,147 | -2,454 | -1,705 |
| Operating Cash Flow | $-11,569 | $-3,790 | $-2,380 | $-2,582 | $-1,497 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -852 | -721 | -564 | -722 | -135 |
| Net Acquisitions | 26,037 | 26,037 | N/A | N/A | N/A |
| Other Investing Activity | 214 | 0 | 0 | -8 | 0 |
| Investing Cash Flow | $25,399 | $25,316 | $-564 | $-730 | $-135 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 13 | 13 |
| Other Financing Activity | -386 | -198 | -94 | -370 | -205 |
| Financing Cash Flow | $-386 | $-198 | $-94 | $-357 | $-192 |
| Exchange Rate Effect | -124 | -202 | -134 | 157 | -2 |
| Beginning Cash Position | 6,678 | 6,678 | 6,678 | 10,190 | 10,190 |
| End Cash Position | 19,998 | 27,804 | 3,506 | 6,678 | 8,364 |
| Net Cash Flow | $13,320 | $21,126 | $-3,172 | $-3,512 | $-1,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,569 | -3,790 | -2,380 | -2,582 | -1,497 |
| Capital Expenditure | -852 | -721 | -564 | -722 | -135 |
| Free Cash Flow | -12,421 | -4,511 | -2,944 | -3,304 | -1,632 |